Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...
The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the brain many years before symptoms arise can delay the onset of Alzheimer's ...
McDade said this study has the longest-running data for any patients who started amyloid-lowering biologics while they were still free of symptoms. “We think that there’s a delay in the ...
The kidneys become hard and small with buildup of amyloid. It is important for the nurse to assess the extent of kidney involvement in amyloidosis and the development of the nephrotic syndrome.
AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.
It is thought to be caused by a build-up of amyloid and tau in the brain, which clump together and from plaques and tangles that make it harder for the brain to work properly. Eventually ...
Now, American scientists say women who already have a build-up of one toxic protein — amyloid — in the brain accumulated another protein — tau — at a faster rate than their male counterparts.
People with smartwatches might have a better way than counting steps to monitor their heart health Dividing average daily heart rate by the number of daily steps is a more important measure of ...
SATURDAY, March 22, 2025 (HealthDay News) -- There’s nothing like the feeling of years of hard work paying off -- when you can finally transition to a life of non-work activities, whether it’s ...
Women might not need to undergo bladder testing to manage their urinary incontinence A clinical evaluation worked just as well as invasive bladder testing in finding a treatment that eased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results